The court last month ordered an “interim status quo” on the deal, pending a decision on a petition for a probe into alleged insider trading.
High Court Lifts Stay on Sun Pharma’s $3.2 Billion Ranbaxy Takeover
The court last month ordered an “interim status quo” on the deal, pending a decision on a petition for a probe into alleged insider trading.